Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Nickel (II)-induced apoptosis and G2/M enrichment

Lee SH, Kim DK, Seo YR, Woo KM, Kim CS, Cho MH

  • KMID: 1109301
  • Exp Mol Med.
  • 1998 Sep;30(3):171-176.
Treatment with certain DNA-damaging agents induce a complex cellular response comprising pertubation of cell cycle progression and/or apoptosis on proliferating mammalian cells. Our studies were focused on the cellular effects of nickel (II)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Altered remodeling of nucleolar machineries in cultured hepatocytes treated with thioacetamide

Jeong JS, Han SY, Kim YH, Choi YC

Thioacetamide (TA) is converted into a hyperacetylating agent which causes hepatic necrosis, regeneration, cirrhosis and cancerous transformation. One of the most characteristic toxicities of TA in rat is observed with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis

Kim SK, Cho SM, Kim H, Seok H, Kim SO, Kwon TK, Chang JS

  • KMID: 2154238
  • Exp Mol Med.
  • 2013 Apr;45(4):e19.
New colchicine analogs have been synthesized with the aim of developing stronger potential anticancer activities. Among the analogs, CT20126 has been previously reported to show immunosuppressive activities. Here, we report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells

Hong YB, Kang HJ, Kim HJ, Rosen EM, Dakshanamurthy S, Rondanin R, Baruchello R, Grisolia G, Daniele S, Bae I

Resveratrol has been reported to possess cancer preventive properties. In this study, we analyzed anti-tumor activity of a newly synthesized resveratrol analog, cis-3,4',5-trimethoxy-3'-hydroxystilbene (hereafter called 11b) towards breast and pancreatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr